JP2024522079A5 - - Google Patents

Info

Publication number
JP2024522079A5
JP2024522079A5 JP2023571846A JP2023571846A JP2024522079A5 JP 2024522079 A5 JP2024522079 A5 JP 2024522079A5 JP 2023571846 A JP2023571846 A JP 2023571846A JP 2023571846 A JP2023571846 A JP 2023571846A JP 2024522079 A5 JP2024522079 A5 JP 2024522079A5
Authority
JP
Japan
Prior art keywords
mitoferrin
inhibitor
cancer
activity
use according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023571846A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024522079A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2022/063693 external-priority patent/WO2022243502A1/en
Publication of JP2024522079A publication Critical patent/JP2024522079A/ja
Publication of JP2024522079A5 publication Critical patent/JP2024522079A5/ja
Pending legal-status Critical Current

Links

JP2023571846A 2021-05-21 2022-05-20 がん治療における使用のためのミトフェリン-2のインヒビター Pending JP2024522079A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP21175355 2021-05-21
EP21175355.3 2021-05-21
PCT/EP2022/063693 WO2022243502A1 (en) 2021-05-21 2022-05-20 Inhibitors of mitoferrin-2 for use in treating cancer

Publications (2)

Publication Number Publication Date
JP2024522079A JP2024522079A (ja) 2024-06-11
JP2024522079A5 true JP2024522079A5 (https=) 2025-03-10

Family

ID=76059785

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023571846A Pending JP2024522079A (ja) 2021-05-21 2022-05-20 がん治療における使用のためのミトフェリン-2のインヒビター

Country Status (4)

Country Link
US (1) US20240240190A1 (https=)
EP (1) EP4341402A1 (https=)
JP (1) JP2024522079A (https=)
WO (1) WO2022243502A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023118294A1 (en) * 2021-12-22 2023-06-29 Vib Vzw Inhibition of mitoferrin 2 as means for inhibiting cancer and cancer metastasis

Similar Documents

Publication Publication Date Title
Hou et al. Aldehyde dehydrogenase‐2 (ALDH2) opposes hepatocellular carcinoma progression by regulating AMP‐activated protein kinase signaling in mice
Li et al. Liu y
Guo et al. MiR‐199a‐5p is negatively associated with malignancies and regulates glycolysis and lactate production by targeting hexokinase 2 in liver cancer
Hwang et al. Fibulin‐3 is associated with tumour progression and a poor prognosis in nasopharyngeal carcinomas and inhibits cell migration and invasion via suppressed AKT activity
Lin et al. Retracted: Role of STAT3 and vitamin D receptor in EZH2‐mediated invasion of human colorectal cancer
Wang et al. Investigation of serum miR-411 as a diagnosis and prognosis biomarker for non-small cell lung cancer.
Peng et al. LACTB promotes metastasis of nasopharyngeal carcinoma via activation of ERBB3/EGFR-ERK signaling resulting in unfavorable patient survival
Tan et al. High PRMT5 expression is associated with poor overall survival and tumor progression in bladder cancer
Schwartz et al. High‐resolution transcriptomic and epigenetic profiling identifies novel regulators of COPD
Sun et al. MicroRNA-186-5p serves as a diagnostic biomarker in atherosclerosis and regulates vascular smooth muscle cell proliferation and migration
Wei et al. Long non-coding RNA ZEB1-AS1 promotes glioma cell proliferation, migration and invasion through regulating miR-577.
Han et al. Breast cancer epidemiology of the working-age female population reveals significant implications for the South Korean economy
Li et al. MiR-92b inhibited cells EMT by targeting Gabra3 and predicted prognosis of triple negative breast cancer patients.
Du et al. PAICS is related to glioma grade and can promote glioma growth and migration
Liu et al. Knockdown of thrombospondin 2 inhibits metastasis through modulation of PI3K signaling pathway in uveal melanoma cell line M23.
Zhao et al. Lactylation increases the stability of RBM15 to drives m6A modification in non‐small‐cell lung cancer cells
Jia et al. RETRACTED ARTICLE: LncRNA MCM3AP-AS1 Promotes Cell Proliferation and Invasion Through Regulating miR-543-3p/SLC39A10/PTEN Axis in Prostate Cancer
Guo et al. Overexpression of microRNA-129-5p in glioblastoma inhibits cell proliferation, migration, and colony-forming ability by targeting ZFP36L1
Zhao et al. Inhibition of ribosomal RNA processing 15 Homolog (RRP15), which is overexpressed in hepatocellular carcinoma, suppresses tumour growth via induction of senescence and apoptosis
Xu et al. CBX2-mediated suppression of SIAH2 triggers WNK1 accumulations to promote glycolysis in hepatocellular carcinoma
Li et al. RETRACTED ARTICLE: miR-202-3p negatively regulates MMP-1 to inhibit the proliferation, migration and invasion of lung adenocarcinoma cells
Zhou et al. miR‐942‐5p inhibits proliferation, metastasis, and epithelial‐mesenchymal transition in colorectal cancer by targeting CCBE1
Han et al. Clinicopathologic and prognostic significance of the zinc finger of the cerebellum family in invasive breast cancer
JP2024522079A5 (https=)
Li et al. Procollagen‑lysine, 2‑oxoglutarate 5‑dioxygenase 1 increases cellular proliferation and colony formation capacity in lung cancer via activation of E2F transcription factor 1